Last reviewed · How we verify
Standard dose rosuvastatin
At a glance
| Generic name | Standard dose rosuvastatin |
|---|---|
| Also known as | rosuvastatin |
| Sponsor | Kobe University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke (PHASE2, PHASE3)
- Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (PHASE4)
- Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome (NA)
- A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI) (PHASE3)
- Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT (NA)
- Efficacy of Statins Among Major Depressive Disorder (PHASE3)
- Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI (PHASE4)
- A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |